Rifampicin, myambutol, Isoxyl, and capreomycin as combination partners in animal experiments.
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000097:blood / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004977:Ethambutol / Q000097:blood / Q000627:therapeutic use*; D009164:Mycobacterium Infections / Q000097:blood / Q000188:drug therapy; D010670:Phenylthiourea / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use*; D011817:Rabbits; D012293:Rifampin / Q000097:blood / Q000627:therapeutic use*; D014376:Tuberculosis / Q000097:blood / Q000188:drug therapy
D000995:Antitubercular Agents; D004338:Drug Combinations; D002207:Capreomycin; C100189:thiocarlide; D010670:Phenylthiourea; D004977:Ethambutol; D012293:Rifampin